The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL

Júlio C Possati-Resende, José H T G Fregnani, Ligia M Kerr, Edmundo C Mauad, Adhemar Longatto-Filho, Cristovam Scapulatempo-Neto, Júlio C Possati-Resende, José H T G Fregnani, Ligia M Kerr, Edmundo C Mauad, Adhemar Longatto-Filho, Cristovam Scapulatempo-Neto

Abstract

The objective of this study was to compare the accuracies of double staining for p16/Ki-67 and the molecular test for high-risk HPV (hr-HPV) to identify high-grade cervical intraepithelial neoplasia (CIN2/CIN3) in women with cervical cytology of atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL). Data were collected from 201 women who underwent cervical cytology screening in the Barretos Cancer Hospital and their results were categorized as ASC-US (n=96) or LSIL (n=105). All patients underwent colposcopy with or without cervical biopsy for diagnosis of CIN2/CIN3. The hr-HPV test (Cobas 4800 test) and immunocytochemistry were performed to detect biomarkers p16/Ki-67 (CINtec PLUS test). Two samples (1 ASC-US/1 LSIL) were excluded from the analysis due to inconclusive results of the histologic examination. There were 8 cases of CIN2/CIN3 among 95 women with ASC-US (8.4%), and 23 cases of CIN2/CIN3 among 104 women with LSIL (22.1%). In the group of women with ASC-US, the sensitivity and specificity in diagnosing CIN2/CIN3 were 87.5% and 79.5% for the HPV test and 62.5% and 93.1% for p16/Ki-67. Among women with LSIL, the sensitivity and specificity in the diagnosis of CIN2/CIN3 were 87% and 34.7% for the HPV test and 69.6% and 75.3% for immunocytochemistry. Superior performance was observed for p16/Ki-67 double staining, especially among women under 30 for whom the test had an area under the ROC curve of 0.762 (p<0.001). Both p16/Ki-67 double staining and the hr-HPV DNA test had similar performance in predicting high-grade cervical intraepithelial neoplasia among women with ASC-US. The best performance was observed in women aged >30 years. In younger women (≤30 years) with LSIL, p16/Ki-67 had greater accuracy in identifying precursor lesions. Among women >30 years diagnosed with LSIL, the two methods showed similar performance.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Flowchart of the colposcopic examination…
Fig 1. Flowchart of the colposcopic examination and research p16/Ki-67 and hr-HPV.
ASC-US: atypical squamous cells of undetermined significance; LSIL: low-grade squamous intraepithelial lesion; EC: endocervical curettage.
Fig 2. Examples of positive tests for…
Fig 2. Examples of positive tests for Ki-67 (red) and p16 (brown).
(A) and (D), 200x magnification; (B) and (C), 400x magnification.
Fig 3. Correlation between cervical cytology and…
Fig 3. Correlation between cervical cytology and colposcopy and histological findings.
CIN1, 2, 3: cervical intraepithelial neoplasia grade 1, 2 and 3; ASC-US: atypical squamous cells of undetermined significance; LSIL: low-grade squamous intraepithelial lesion. (*) Two cases with inconclusive biopsies (1 ASC-US and 1 LSIL) were excluded.
Fig 4. hr-HPV test according to the…
Fig 4. hr-HPV test according to the colpo-histological diagnosis.
HPV-16: positive cytological samples for subtype HPV-16. HPV-18: positive cytological samples for subtype HPV-18. Twelve Other HPV subtypes: positive cytology samples for one or more subtypes of HPV belonging to group 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68. CIN 1, 2, 3: cervical intraepithelial neoplasia grade 1, 2 and 3.

References

    1. Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries IARC Scientific Publications N°. 15. Lyon: IARC Press; 1988.
    1. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810–9.
    1. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;91(4):626–31.
    1. Allen K, Holladay EB. Risk Management for the Cytology Laboratory. Raleigh, NC: American Society for Cytotechnology; 2002.
    1. Sawaya GF, Grimes DA. New technologies in cervical cytology screening: a word of caution. Obstet Gynecol. 1999;94(2):307–10.
    1. Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, et al. New Technologies and Procedures for Cervical Cancer Screening. Vaccine. 2012;30, Supplement 5(0):F107–F16.
    1. Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Ho L, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer. 2013;108(4):908 10.1038/bjc.2013.22
    1. de Oliveira CM, Fregnani JH, Carvalho JP, Longatto-Filho A, Levi JE. Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil. BMC Cancer. 2013;13:357 10.1186/1471-2407-13-357
    1. Lapierre SG, Sauthier P, Mayrand M-H, Dufresne S, Petignat P, Provencher D, et al. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol. 2012;50(4):1240–4. 10.1128/JCM.06656-11
    1. Stoler MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL. High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology Results From the ATHENA HPV Study. Am J Clin Pathol. 2011;135(3):468–75. 10.1309/AJCPZ5JY6FCVNMOT
    1. White C, Keegan H, Pilkington L, Ruttle C, Kerr P, Sharp L, et al. Evaluation of the Clinical Performance of the cobas 4800 HPV Test in Patients Referred for Colposcopy. J Clin Microbiol. 2013;51(10):3415–7. 10.1128/JCM.01949-13
    1. Mateos Lindemann ML, Rodriguez Dominguez MJ, Chacón de Antonio J, Sandri MT, Tricca A, Sideri M, et al. Analytical Comparison of the cobas HPV Test with Hybrid Capture 2 for the Detection of High-Risk HPV Genotypes. J Mol Diagn. 2012;14(1):65–70. 10.1016/j.jmoldx.2011.09.005
    1. Wong AA, Fuller J, Pabbaraju K, Wong S, Zahariadis G. Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J Clin Microbiol. 2012;50(1):25–9. 10.1128/JCM.05400-11
    1. Wright TC Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287(16):2120–9.
    1. Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations. Diagn Cytopathol. 2013;41(1):35–40. 10.1002/dc.21757
    1. Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prins F, Malinowski DP. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. Journal of oncology. 2012;2012.
    1. Schmidt D, Bergeron C, Denton KJ, Ridder R. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol. 2011;119(3):158–66. 10.1002/cncy.20140
    1. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154–62. 10.1158/1078-0432.CCR-12-0270
    1. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System. JAMA. 2002;287(16):2114–9.
    1. Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, et al. 2011 Colposcopic Terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166–72.
    1. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285(11):1500–5.
    1. Kisser A, Zechmeister-Koss I. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology. BJOG: An International Journal of Obstetrics & Gynaecology. 2015;122(1):64–70.
    1. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol. 1999;181(3):560–6.
    1. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188(6):1406–12.
    1. Walker JL, Wang SS, Schiffman M, Solomon D. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol. 2006;195(2):341–8.
    1. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand M-H, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26:K29–K41. 10.1016/j.vaccine.2008.06.019
    1. Waldstrøm M, Christensen RK, Ørnskov D. Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Cancer Cytopathol. 2013;121(3):136–45. 10.1002/cncy.21233
    1. Loghavi S, Walts AE, Bose S. CINtec® PLUS dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion. Diagn Cytopathol. 2013;41(7):582–7. 10.1002/dc.22900
    1. Donà MG, Vocaturo A, Giuliani M, Ronchetti L, Rollo F, Pescarmona E, et al. p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Oncol. 2012;126(2):198–202. 10.1016/j.ygyno.2012.05.004

Source: PubMed

3
Tilaa